Progesterone Ultrasensitive

If you are tracking ovulation, trying to conceive, going through IVF, or trying to understand an unpredictable cycle, the progesterone number you get back can change what you do next. The catch is that not all progesterone tests are equal, especially at the low concentrations where most clinical decisions actually live.

This test uses a high-precision lab technique called LC-MS/MS (liquid chromatography-tandem mass spectrometry, a method that identifies molecules by their exact mass). It is more specific than the standard immunoassay-based progesterone tests run in most clinical labs, which often overestimate progesterone at low concentrations and can confuse it with closely related steroid molecules.

What This Test Actually Measures

Progesterone is a steroid hormone. Outside of pregnancy, your ovaries make most of it, with a sharp rise after ovulation as the corpus luteum (the structure left behind by the released egg) produces it. During pregnancy, the placenta takes over as the main source between 6 and 9 weeks and continues producing it to maintain gestation.

What the level reflects depends entirely on when in your cycle the blood was drawn and your reproductive stage. In women not taking oral contraceptives, plasma progesterone was roughly 24 times higher during the luteal phase than during the follicular phase in one large LC-MS/MS reference study. A single number stripped of timing context tells you almost nothing.

This is why the ultrasensitive LC-MS/MS approach matters. It performs reliably across men, premenopausal women, and postmenopausal women, with laboratory variability below 3% and reproducibility above 98% across these groups in one validated assay. Standard immunoassays often overestimate low progesterone values and can produce results inaccurate enough to drive the wrong clinical decision.

Why Ovulation and Luteal Function Matter

In a natural cycle, a rise in luteal progesterone is the clearest blood signal that ovulation occurred and that the corpus luteum is producing enough hormone to potentially support implantation. Professional society guidance and prospective studies in eumenorrheic subfertile women treat a midluteal serum progesterone above about 3 ng/mL as presumptive and sufficient evidence of recent ovulation, making it one of the most accurate single-marker tests of ovulation available.

If you have regular cycles but unexplained infertility, irregular bleeding, or suspected luteal phase issues, a well-timed progesterone reading is one of the most direct windows you have into whether ovulation is happening and whether the post-ovulation environment is hormonally adequate.

Why It Matters in IVF and Frozen Embryo Transfer

In frozen embryo transfer cycles, low progesterone around the time of transfer is consistently linked to worse outcomes. A meta-analysis of cycles using vaginal progesterone with blastocyst transfers analyzed studies that defined low progesterone using thresholds below 10 ng/mL. Women whose serum progesterone was above those study-specific thresholds had about 47% higher ongoing pregnancy or live birth rates, 31% higher clinical pregnancy rates, and 38% lower miscarriage rates than those below.

In one hormone replacement frozen embryo transfer cohort, women with progesterone below 35 nmol/L had a 14 percentage point lower adjusted ongoing pregnancy rate (44% versus 58%). And in programmed cycles using oral dydrogesterone, women in the lowest quarter of drug or metabolite levels had ongoing pregnancy rates of just 6% to 8% compared with 27% to 28% in those above the lowest quarter.

In fresh IVF cycles, the picture flips. Elevated progesterone on the day of the ovulation trigger is associated with lower live birth and clinical pregnancy rates with day-3 embryo transfer, though not consistently with day-5 (blastocyst) transfer. High and low both carry meaning, and the meaning depends on cycle type, embryo stage, and exactly when the sample is drawn.

Why It Matters in Pregnancy

During pregnancy, progesterone reflects placental steroidogenesis (the placenta's hormone-making activity) and the body's capacity to maintain gestation. Maternal levels rise as the placenta matures, and shifts in progesterone metabolite ratios in the third trimester appear to participate in the hormonal changes that precede birth.

Dysregulated placental progesterone production has been implicated in major obstetric complications. While a single progesterone measurement in pregnancy is not by itself diagnostic, deviations from expected gestational trends can prompt closer evaluation.

Why the Assay Method Is Not a Technicality

Routine progesterone is usually measured by immunoassay, which uses antibodies to detect the hormone. Immunoassays are fast and cheap but can cross-react with structurally similar steroids and tend to overestimate progesterone at low concentrations. In one head-to-head study, immunoassay consistently read higher than LC-MS/MS, and immunoassay values below about 5 nmol/L were too imprecise to be used quantitatively.

This matters most when you are near a clinical threshold. In IVF samples, different automated immunoassay analyzers produced systematically different mean progesterone values, leading the authors to conclude that decision thresholds should be interpreted in a laboratory- and method-specific way. LC-MS/MS sidesteps much of this cross-reactivity by identifying progesterone based on its exact mass and chemical fingerprint.

That does not mean LC-MS/MS is automatically perfect. Inter-laboratory variability persists even after calibration harmonization, and imprecision can worsen at very low concentrations. The advantage is real, but interpretation still depends on the specific lab, the specific assay, and your clinical context.

Tracking Your Trend

For progesterone, a single reading is almost never enough on its own. Levels swing dramatically across the menstrual cycle, across pregnancy, and even within a single day. In one study of women on the final day of oocyte maturation, progesterone fell by 44% between morning and evening, and 70% of women whose morning level was above 1.5 ng/mL had dropped below that threshold by the same evening.

Useful trending depends on holding the right things constant: the same cycle day, the same time of morning, the same lab, the same assay platform, and the same contraceptive status. If you are tracking ovulation, the standard approach is to draw blood about 7 days after presumed ovulation (mid-luteal phase). If you are following a fertility treatment cycle, your clinician will set timing based on the protocol.

For baseline tracking outside of fertility treatment, a sensible cadence is a baseline reading at the right cycle day, a repeat within 1 to 3 cycles if the result is unexpected, and follow-up testing whenever cycle patterns shift or you change a hormonal medication. Avoid drawing conclusions from one isolated value, especially if it sits near a decision threshold.

When Results Can Be Misleading

• Cycle timing: progesterone varies roughly 24-fold between the follicular and luteal phases of the menstrual cycle, so a result drawn at the wrong cycle day cannot be interpreted meaningfully.
• Time of day: progesterone can shift substantially across a single day, with one study showing a 44% drop between morning and evening on the final day of oocyte maturation. Morning collection is preferred and most reference intervals are built from morning samples.
• Oral contraceptives: combined oral contraceptives suppress endogenous progesterone production, so a low result in someone on these medications reflects the medication rather than ovarian or adrenal disease.
• Assay type: immunoassay progesterone readings can run substantially higher than LC-MS/MS readings, especially at low concentrations. Comparing values across different test methods can be misleading.

What to Do With an Out-of-Pattern Result

Because a single progesterone value is so dependent on timing, the first step after an unexpected result is usually to confirm the test conditions: was the cycle day correct, was the draw in the morning, were any hormonal medications in play. If conditions were correct, repeat testing in a subsequent cycle under the same conditions is often the most useful next step.

Beyond that, what to do depends on the question. If you are evaluating ovulation, the workup typically expands to companion hormones (LH, FSH, estradiol) and sometimes pelvic ultrasound to confirm follicular activity. If fertility is the concern, AMH adds ovarian reserve information that progesterone does not capture. If progesterone is being followed in an IVF or frozen embryo transfer cycle, your reproductive endocrinologist will adjust progesterone supplementation or timing based on the result. If progesterone looks unexpectedly high outside of pregnancy or the luteal phase, an evaluation of adrenal steroid pathways (including 17-hydroxyprogesterone and related steroids) may be warranted. Unusual results often warrant a referral to a reproductive endocrinologist or endocrinologist rather than action based on the single number alone.